306 related articles for article (PubMed ID: 22548407)
1. Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options.
Grace JA; Herath CB; Mak KY; Burrell LM; Angus PW
Clin Sci (Lond); 2012 Aug; 123(4):225-39. PubMed ID: 22548407
[TBL] [Abstract][Full Text] [Related]
2. Liver fibrosis: a balance of ACEs?
Warner FJ; Lubel JS; McCaughan GW; Angus PW
Clin Sci (Lond); 2007 Aug; 113(3):109-18. PubMed ID: 17600527
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors.
Huang ML; Li X; Meng Y; Xiao B; Ma Q; Ying SS; Wu PS; Zhang ZS
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):e1-6. PubMed ID: 19793108
[TBL] [Abstract][Full Text] [Related]
4. Hepatic fibrosis and the renin-angiotensin system.
Abbas G; Silveira MG; Lindor KD
Am J Ther; 2011 Nov; 18(6):e202-8. PubMed ID: 20535005
[TBL] [Abstract][Full Text] [Related]
5. Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension.
Shim KY; Eom YW; Kim MY; Kang SH; Baik SK
Korean J Intern Med; 2018 May; 33(3):453-461. PubMed ID: 29462546
[TBL] [Abstract][Full Text] [Related]
6. Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.
Grace JA; Klein S; Herath CB; Granzow M; Schierwagen R; Masing N; Walther T; Sauerbruch T; Burrell LM; Angus PW; Trebicka J
Gastroenterology; 2013 Oct; 145(4):874-884.e5. PubMed ID: 23796456
[TBL] [Abstract][Full Text] [Related]
7. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
8. The role of the renin-angiotensin system in liver fibrosis.
Munshi MK; Uddin MN; Glaser SS
Exp Biol Med (Maywood); 2011 May; 236(5):557-66. PubMed ID: 21508249
[TBL] [Abstract][Full Text] [Related]
9. Liver disease and the renin-angiotensin system: recent discoveries and clinical implications.
Lubel JS; Herath CB; Burrell LM; Angus PW
J Gastroenterol Hepatol; 2008 Sep; 23(9):1327-38. PubMed ID: 18557800
[TBL] [Abstract][Full Text] [Related]
10. Renin angiotensin system in liver diseases: Friend or foe?
Simões E Silva AC; Miranda AS; Rocha NP; Teixeira AL
World J Gastroenterol; 2017 May; 23(19):3396-3406. PubMed ID: 28596676
[TBL] [Abstract][Full Text] [Related]
11. Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options.
Rajapaksha IG; Gunarathne LS; Angus PW; Herath CB
J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33670126
[TBL] [Abstract][Full Text] [Related]
12. Blockade of renin-angiotensin system in antifibrotic therapy.
Yoshiji H; Kuriyama S; Fukui H
J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S93-5. PubMed ID: 17567477
[TBL] [Abstract][Full Text] [Related]
13. Regulation of angiotensin II receptors beyond the classical pathway.
Horiuchi M; Iwanami J; Mogi M
Clin Sci (Lond); 2012 Aug; 123(4):193-203. PubMed ID: 22548405
[TBL] [Abstract][Full Text] [Related]
14. [Renin-angiotensin system in atherosclerosis].
Fukuda D; Sata M
Nihon Rinsho; 2006 Apr; 64(4):805-9. PubMed ID: 16613201
[TBL] [Abstract][Full Text] [Related]
15. The role of renin-angiotensin system modulation on treatment and prevention of liver diseases.
Moreira de Macêdo S; Guimarães TA; Feltenberger JD; Sousa Santos SH
Peptides; 2014 Dec; 62():189-96. PubMed ID: 25453980
[TBL] [Abstract][Full Text] [Related]
16. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
Falkenhahn M; Gohlke P; Paul M; Stoll M; Unger T
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S6-13. PubMed ID: 7898096
[TBL] [Abstract][Full Text] [Related]
17. Recent changes in the landscape of combination RAS blockade.
Epstein BJ; Smith SM; Choksi R
Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
[TBL] [Abstract][Full Text] [Related]
18. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
Krum H; Gilbert RE
J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
[TBL] [Abstract][Full Text] [Related]
19. Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components.
Kurdi M; De Mello WC; Booz GW
Int J Biochem Cell Biol; 2005 Jul; 37(7):1357-67. PubMed ID: 15833268
[TBL] [Abstract][Full Text] [Related]
20. Progression of cardiovascular damage: the role of renin-angiotensin system blockade.
Probstfield JL; O'Brien KD
Am J Cardiol; 2010 Jan; 105(1 Suppl):10A-20A. PubMed ID: 20102969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
